Related Experiment Video

Updated: Jun 6, 2025

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
10:41

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

10.4K

Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities

Rajita Vatapalli1, Alex P Rossi1,2, Ho Man Chan1

  • 1AstraZeneca, Oncology Research and Development, Waltham, MA, USA.

Epigenomics
|November 27, 2024
PubMed

Insights

Epigenetic dysregulation drives cancer development. Targeting these epigenetic mechanisms has yielded successful cancer therapies, with ongoing research exploring new treatment avenues.

Area of Science:

  • Oncology
  • Epigenetics
  • Cancer Therapeutics

Background:

  • Epigenetic dysregulation is a key factor in human cancer development and progression.
  • Understanding these epigenetic alterations provides crucial insights into cancer biology.

Purpose of the Study:

  • To review the role of epigenetic dysregulation in cancer.
  • To discuss the development of novel cancer therapies targeting epigenetic mechanisms.
  • To explore current therapeutic strategies, clinical experiences, and future opportunities in epigenetic cancer treatment.

Main Methods:

  • Literature review of epigenetic dysregulation in cancer.
  • Analysis of drug discovery efforts targeting cancer epigenetics.
  • Examination of clinical development and approval of epigenetic therapeutics.

Main Results:

  • Significant advancements in targeting cancer epigenetic mechanisms over the past two decades.
  • Successful clinical development and regulatory approval of epigenetic cancer therapeutics.
  • Identification of key learnings from clinical experiences with these therapies.

Conclusions:

  • Epigenetic therapies represent a promising area in oncology.
  • Continued research into therapeutic rationale and novel targets will drive future advancements.
  • Clinical insights are crucial for optimizing epigenetic treatment strategies.
Keywords:
Cancer epigeneticsDNA modificationsdrug combinationdrug discoveryhistone modificationssynthetic lethality

More Related Videos

Methylated DNA Immunoprecipitation21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

23.3K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study07:49

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

113

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K